بحث بيانات أعضاء هيئة التدريس - جامعة الزقازيق

/ بحث بيانات أعضاء هيئة التدريس - جامعة الزقازيق

حنان محمد محمود مصطفى النحاس

الموقع الشخصى
السيرة الذاتية

حنان محمد محمود مصطفى النحاس

الكلية الصيدلة - القسم الصيدلانيات
الصيدلانيات

وكيل الكلية لشئون التعليم والطلاب

الدرجات العلمية

بكالوريوس فى الصيدلانيات, -جامعة الزقازيق [1991]
ماجستير فى الصيدلانيات, -جامعة الزقازيق [1996]
دكتوراه فى الصيدلانيات, -جامعة الزقازيق [2001]

الحالة الوظيفية الحالية :

قائم بالعمل

التدرج الوظيفى الأكاديمى

معيد : 6/2/1992
مدرس مساعد : 8/10/1996
مدرس : 27/11/2001
أستاذ مساعد : 24/7/2007
أستاذ : 26/3/2013

الأبحاث العلمية

1 - AStudy of certain formulations of Controlled drug delivery systems

2 - Liposomal gel as Ocular Delivery System for Diclofenac sodium: In- Vitro and In-Vivo Studies (1434).

3 - FORMULATION AND EVALUATION OF CARBAMAZEPINE 200 MG CHEWABLE TABLETS USING CYCLODEXTRINS (1433).

4 - Propolis organogel as a novel topical delivery system for treating wounds (1435).

5 - Formulation and Evaluation of Carbamazepine 200 mg Controlled Release Tablets Using Different HPMC Grades Formulation and Evaluation of Carbamazepine 200 mg Controlled Release Tablets Using Different HPMC Grades Formulat (1434).

6 - FORMULATION AND EVALUATION OF CARBAMAZEPINE SOLID DISPERSIONS WITH POLYETHYLENE GLYCOL 6000 AND THEIR INCORPORATION INTO TABLETS (1434).

7 - Development and Characterization of Controlled Release Ketoprofen Microspheres (1433).

8 - Encapsulation in a rapid-release liposomal formulation enhances the anti-tumor efficacy of pemetrexed in a murine solid mesothelioma-xenograft model (1437).

9 - BUCCOADHESIVE TABLETS FOR DELIVERY OF VERAPAMIL HCL: DESIGN, IN VITRO ANALYSIS AND IN-VIVO EVALUATION Fakhr El Din S. Ghazy, Mohamed A. Gad, Hanan M. El-Nahas, Noura G. Eissa . Bull. Pharm. Sci., Assiut University, Vol. 35, Part 1, 17-25(01 (1435).

10 - Atorvastatin Calcium Solid Dispersion in Floating Tablets for Hypolipedmic Effect. (1437).

11 - OPTIMISATION AND CHARACETRISATION OF EUDRAGIT S 100 MICROSPONGES OF FLUCONAZOLE (1437).

12 - Optimization and Characterization of Eudragit S 100 Microsponges of Fluconazole (1437).

13 - Optimization of injectable PLGA in-situ forming implants of anti-psychotic risperidone via Box-Behnken Design (1441).

14 - Development, optimization, and evaluation of PEGylated brucine-loaded PLGA nanoparticles (1441).

15 - Comparative Study of PLGA in-situ Implant and Nanoparticle Formulations of Entecavir; in-vitro and in-vivo evaluation (1441).

16 - Brucine PEGylated nanoemulsion: In vitro and in vivo evaluation (1442).

17 - Fast disintegrating tablet of Doxazosin Mesylate nanosuspension: Preparation and characterization (1442).

18 - An overview of PLGA in-situ forming implants based on solvent exchange technique: effect of formulation components and characterization (1442).

19 - Morphological characterization of optimized risperidone-loaded in-situ gel forming implants with pharmacokinetic and behavioral assessments in rats (1443).

20 - Basic Concepts of Nanoemulsion and its Potential application in Pharmaceutical, Cosmeceutical and Nutraceutical fields (1442).

21 - A Review Article on the Basic Concepts of Drug Delivery Systems as Targeting Agents (1442).

22 - Investigation of Alogliptin-Loaded In Situ Gel Implants by 23 Factorial Design with Glycemic Assessment in Rats (1444).

23 - Formulation and evaluation of fast dissolving tablets of haloperidol solid dispersion (1444).

24 - Development, Characterization and Optimization of the Anti-Inflammatory Influence of Meloxicam Loaded into a Eucalyptus Oil-Based Nanoemulgel (1443).

25 - Optimization of mirtazapine loaded into mesoporous silica nanostructures via Box-Behnken design: in-vitro characterization and in-vivo assessment (1443).

26 - Brain-targeted delivery of Valsartan using solid lipid nanoparticles labeled with Rhodamine B; a promising technique for mitigating the negative effects of stroke (1444).

27 - Significant of injectable brucine PEGylated niosomes in treatment of MDA cancer cells (1443).

28 - Evaluation of ceftriaxone pharmacokinetics in hospitalized Egyptian pediatric patients (1445).

29 - Development of depot PLGA-based in-situ implant of Linagliptin: Sustained release and glycemic control (1444).

30 - Optimization of Potential Nanoemulgels for Boosting Transdermal Glimepiride Delivery and Upgrading Its Anti-Diabetic Activity (1444).

31 - Tailoring Risperidone-Loaded Glycethosomal In Situ Gels Using Box–Behnken Design for Treatment of Schizophrenia-Induced Rats via Intranasal Route (1445).

32 - The Exploitation of pH-Responsive Eudragit-Coated Mesoporous Silica Nanostructures in the Repurposing of Terbinafine Hydrochloride for Targeted Colon Cancer Inhibition: Design Optimization, In Vitro Characterization, and Cytotoxicity Assessment (1445).

33 - Design of mirtazapine solid dispersion with different carriers’ systems: optimization, in vitro evaluation, and bioavailability assessment (1444).

34 - Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs (1445).

35 - Association of SLC22A1, SLC47A1, and KCNJ11 polymorphisms with efficacy and safety of metformin and sulfonylurea combination therapy in Egyptian patients with type 2 diabetes (1445).

36 - Maximizing the Use of Ivermectin Transethosomal Cream in the Treatment of Scabies (1446).

37 - The assessment of pharmacokinetics and neuroprotective effect of berberine hydrochloride-embedded albumin nanoparticles via various administration routes: comparative in-vivo studies in rats (1446).

38 - Evaluation of Mucoadhesive Nano-Bilosomal In Situ Gels Containing Anti-Psychotic Clozapine for Treatment of Schizophrenia: In Vitro and In Vivo Studies (1446).

39 - Sustained linagliptin administration: superior glycemic control and less pancreatic injury in diabetic rats (1446).

40 - Experimental Investigation into the Design, Optimization, Toxicity, and Anti-Viral Efficacy of Proliposomes Loaded with Ivermectin Against Infectious Bronchitis Virus Using an Embryonated Chicken Egg Model (1446).

41 - Oral bioavailability enhancement of doxazosin mesylate: Nanosuspension versus self-nanoemulsifying drug delivery systems (1445).

42 - 24 Factorial Design Formulation Optimization and In vitro Characterization of Desloratadine Nanosuspension Prepared Using Antisolvent Precipitation. (1445).

43 - Exploring Ventilator-Associated Pneumonia: Microbial Clues and Biomarker Insights from a Retrospective Study (1446).

44 - Polymeric linagliptin nanoparticles as a sustained release treatment for type 2 diabetes (1445).

المجالات البحثية